Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI).
- DOI
- 10.1007/s10147-026-03001-6
- Published
- 2026 May
- Container
- International journal of clinical oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10147-026-03001-6,
title = {Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI).},
author = {Shibuki T and Yamashita R and Hashimoto T and Fujisawa T and Imai M and Yuda J and Kuwata T and Misumi T and Nakamura Y and Bando H and Kojima K and Tokioka S and Chiba I and Nakaya N and Hozawa A and Koshiba S and Fuse N and Saito S and Shimizu R and Park WY and Kinoshita K and Yoshino T},
year = {2026},
journal = {International journal of clinical oncology},
doi = {10.1007/s10147-026-03001-6},
url = {https://doi.org/10.1007/s10147-026-03001-6}
}RIS
TY - JOUR TI - Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI). AU - Shibuki T AU - Yamashita R AU - Hashimoto T AU - Fujisawa T AU - Imai M AU - Yuda J AU - Kuwata T AU - Misumi T AU - Nakamura Y AU - Bando H AU - Kojima K AU - Tokioka S AU - Chiba I AU - Nakaya N AU - Hozawa A AU - Koshiba S AU - Fuse N AU - Saito S AU - Shimizu R AU - Park WY AU - Kinoshita K AU - Yoshino T PY - 2026 JO - International journal of clinical oncology DO - 10.1007/s10147-026-03001-6 UR - https://doi.org/10.1007/s10147-026-03001-6 ER -
APA
T, S., R, Y., T, H., T, F., M, I., J, Y., T, K., T, M., Y, N., H, B., K, K., S, T., I, C., N, N., A, H., S, K., N, F., S, S., R, S., WY, P., K, K., & T, Y. (2026). Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI).. International journal of clinical oncology. https://doi.org/10.1007/s10147-026-03001-6
Source records
- pubmed · retrieved 2026-09-26T14:55:31.190Z